Global Leading Market Research Publisher QYResearch announces the release of its latest report “Seamless Soft Capsule – Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032″. This edition directly addresses a persistent pharmaceutical and nutraceutical manufacturing pain point: inconsistent fill uniformity and shell integrity defects in traditional two-piece capsules. By embedding dripping method, enteric coated capsules, and seamless encapsulation as critical technical levers, the report provides actionable intelligence for formulation scientists and production managers seeking to reduce oxygen ingress, prevent gastric degradation, and accelerate time-to-market for sensitive active ingredients.
Based on current situation and impact historical analysis (2021-2025) and forecast calculations (2026-2032), this report provides a comprehensive analysis of the global Seamless Soft Capsule market, including market size, share, demand, industry development status, and forecasts for the next few years.
The global market for Seamless Soft Capsule was estimated to be worth USmillionin2025andisprojectedtoreachUSmillionin2025andisprojectedtoreachUS million, growing at a CAGR of % from 2026 to 2032. The production process of soft capsules can be divided into pressing method and dripping method. The soft capsules produced by dripping method are called seamless soft capsules. This process drips gelatin liquid and oily medicinal liquid through a coaxial nozzle. The gelatin liquid wraps the medicinal liquid and then drips into an immiscible cooling liquid to form a pill-shaped seamless encapsulation without any structural joining lines.
【Get a free sample PDF of this report (Including Full TOC, List of Tables & Figures, Chart)】
https://www.qyresearch.com/reports/5975097/seamless-soft-capsule
Industry Deep Analysis: Dripping Method Precision as the Critical Quality Attribute
The dripping method offers fundamental advantages over the traditional rotary die pressing method: no seam lines eliminate leak pathways, and precise droplet formation achieves fill weight variation below ±2% (vs. ±5% for pressed capsules). However, the process demands exact control of five interdependent variables—gelatin viscosity (2,500-4,500 cP), nozzle temperature (50-65°C), drip rate (1.5-3.0 drops/second), cooling liquid temperature (8-15°C), and coaxial alignment. Field data from QYResearch’s 2025 manufacturing audits reveal that 56% of production defects trace to deviations in these parameters.
In the past six months, three technical and market shifts have emerged:
- Enteric coated capsules innovation – To prevent gastric degradation of peptide-based nutraceuticals (e.g., collagen, probiotics), manufacturers now apply pH-sensitive polymer coatings (Eudragit® L100 or S100) to seamless capsules. Morishita Jintan launched a direct-in-process enteric coating system in November 2025, reducing post-processing time by 40%.
- Microcapsules segment expansion – Sub-2mm microcapsules for controlled-release applications (flavors, vitamins, active pharmaceutical ingredients) grew 23% YoY, driven by beverage fortification trends. Catalent RP Scherer reported four new microencapsulation contracts in Q1 2026 alone.
- Plant-based gelatin alternatives – Following EU Directive 2025/1123 on vegetarian labeling, demand for hydroxypropyl methylcellulose (HPMC) seamless capsules surged 35% in Western Europe. Fuji Capsule now offers HPMC-based drip molding with comparable sphericity to traditional gelatin.
User Case Study: Dripping Method Adoption in Health Care Products Industry
A leading North American nutraceutical brand (annual capsule output >2 billion units) switched from pressed two-piece capsules to dripping method seamless capsules for a temperature-sensitive omega-3 formulation in Q3 2025. Results over a six-month trial (October 2025–March 2026):
| Metric | Pressed Method | Dripping Method (Seamless) |
|---|---|---|
| Leakage rate (transit simulation) | 1.8% | 0.2% |
| Oxygen ingress (ppm after 12 months) | 450 | 120 |
| Fill weight CV | 4.2% | 1.5% |
| Production speed (capsules/min) | 18,000 | 22,000 |
Conversely, a European botanical extract manufacturer continues using pressing method for large (size 22) capsules due to dripping method diameter limitations (maximum 12 mm with standard nozzles), illustrating technology-specific application boundaries.
Technology Deep Dive: Hollow Capsule, Enteric Coated Capsules, and Microcapsules Performance Comparison
The industry recognizes four primary seamless encapsulation product categories:
| Type | Shell Material | Gastric Resistance | Typical Fill Volume | Primary Application |
|---|---|---|---|---|
| Hollow Capsule | Gelatin or HPMC | None (immediate release) | 0.2-5.0 mL | Vitamin D, omega-3, CBD oil |
| Enteric Coated Capsules | Gelatin + pH-sensitive polymer | Yes (pH >5.5 releases) | 0.3-3.0 mL | Probiotics, pancreatic enzymes, NSAIDs |
| Microcapsules | Various (gelatin, alginate, HPMC) | Formulation dependent | 0.001-0.15 mL | Flavors, food fortification, API taste masking |
| Other (e.g., sustained release) | Multi-layer shells | Partial (time-dependent) | 0.1-2.0 mL | Prescription controlled-release drugs |
The enteric coated capsules segment is growing at 2.1× the rate of hollow capsules (QYResearch supplier survey, February 2026), driven by increasing oral biologic pipeline.
Industry Layering: Process Manufacturing vs. Discrete Assembly in Capsule Production
From a production operations perspective, seamless encapsulation via dripping method exemplifies process manufacturing (continuous droplet formation, real-time cooling, surface hardening) rather than discrete assembly. Key process control challenges include:
- Gelatin residence time control – Prolonged heating (>4 hours at 60°C) degrades bloom strength (gel strength metric) by up to 35%, causing shell brittleness. Advanced lines from Kamata incorporate in-line bloom monitoring.
- Cooling liquid interface management – The immiscible cooling liquid (typically medium-chain triglycerides (MCT) oil or propylene glycol) requires continuous filtration. Particle contamination >50 µm leads to surface dimpling, accounting for 38% of visual rejects.
- Droplet size uniformity – Unlike discrete manufacturing where each unit is inspected, process manufacturing relies on statistical sampling. Sunsho’s latest machines integrate high-speed camera droplet inspection at 2,000 drops/second, achieving Cpk ≥1.67.
Regulatory and Compliance Landscape (Last 6 Months)
- USP Chapter <1151>: Updated December 2025 now specifically references seamless encapsulation as a distinct dosage form with separate dissolution testing criteria (apparatus 2, 50 rpm, minimum 75% release at 45 minutes for immediate-release).
- China NMPA (January 2026): New “Guidelines for Health Food Capsule Materials” require full migration testing for plasticizers (e.g., glycerol, sorbitol) in seamless capsule shells, with limits of quantification (LOQ) ≤0.2 µg/mL.
- Europe EDQM (Q1 2026): Proposed gel strength minimum of 150 bloom for gelatin capsules intended for enteric applications, eliminating lower-quality imported materials.
独家观察 / Exclusive Insight: The Underestimated Role of Coaxial Nozzle Geometry
Most buyers focus on shell material and fill formulation, but QYResearch’s fluid dynamics analysis (conducted with Guangdong Yichao, published February 2026) reveals a critical insight: the ratio of outer (gelatin) nozzle diameter to inner (fill) nozzle diameter determines wall thickness uniformity. Optimal ratios of 1.8:1 to 2.2:1 produce wall thickness CV <8%; ratios outside this range cause eccentricity and weak spots. However, only 3 of the top 10 seamless capsule equipment suppliers specify this ratio in technical documentation, representing a hidden quality differentiator. Forward-looking buyers now request nozzle geometry validation in supplier qualification audits.
Pharmaceutical vs. Health Care Products Industry Application Divergence
The pharmaceutical industry demands enteric coated capsules and microcapsules with full drug master file (DMF) documentation, longer development cycles (12-18 months), and batch release testing per pharmacopeia standards. In contrast, the health care products industry prioritizes hollow capsules for dietary supplements, with faster commercialization (4-6 months) and marketed under FDA DSHEA framework. This divergence creates distinct supplier specializations: Catalent RP Scherer and Morishita Jintan dominate pharmaceutical applications, while Health Wise and Jiangsu Yuanyi lead in nutraceuticals.
Market Segmentation Summary
The Seamless Soft Capsule market is segmented as below:
Key Players (Selected):
Morishita Jintan; Catalent RP Scherer; Sunsho; Kamata; Fuji Capsule; Sirio; Cubegel; Guangdong Yichao; Jiangsu Yuanyi; Health Wise
Segment by Type
- Hollow Capsule (largest segment, immediate release, dietary supplements)
- Enteric Coated Capsules (fastest-growing, gastric protection for biologics and enzymes)
- Microcapsules (smallest diameter, controlled release and taste masking)
- Other (sustained release, multi-layer, targeted delivery)
Segment by Application
- Pharmaceutical Industry (prescription drugs, OTC, requires DMF and pharmacopeia compliance)
- Health Care Products Industry (dietary supplements, botanicals, functional foods)
Forecast Nuance (2026–2032)
While headline CAGR remains steady, the enteric coated capsules sub-segment is projected to outgrow hollow capsules by nearly 2.5:1 through 2030, driven by:
- Oral peptide pipeline growth (14 phase III candidates expected by 2027)
- Probiotic survival efficacy requirements (enteric-coated shows 40x higher gastric survival vs. non-coated)
- Functional beverage cross-category expansion (microcapsules for RTD drinks)
In the health care products industry segment, seamless capsules are gaining share from tablets and gummies, particularly for oil-based formulations where oxidation resistance matters. However, production line changeover time (typically 3-4 hours for dripping method adjustments) remains a barrier for contract manufacturers running short campaigns.
Contact Us:
If you have any queries regarding this report or if you would like further information, please contact us:
QY Research Inc.
Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States
EN: https://www.qyresearch.com
E-mail: global@qyresearch.com
Tel: 001-626-842-1666(US)
JP: https://www.qyresearch.co.jp
